FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.67B
Enterprise Value 32.49B
Trailing P/E N/A
Forward P/E 1-15.45
PEG Ratio (5 yr expected) 1-0.06
Price/Sales (ttm)72.33
Price/Book (mrq)6.73
Enterprise Value/Revenue 367.47
Enterprise Value/EBITDA 6-12.53

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-548.01%

Management Effectiveness

Return on Assets (ttm)-15.20%
Return on Equity (ttm)-79.66%

Income Statement

Revenue (ttm)36.93M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)420.30%
Gross Profit (ttm)30.69M
EBITDA -198.79M
Net Income Avi to Common (ttm)-284M
Diluted EPS (ttm)-1.85
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)358.56M
Total Cash Per Share (mrq)1.92
Total Debt (mrq)164.47M
Total Debt/Equity (mrq)46.61
Current Ratio (mrq)5.60
Book Value Per Share (mrq)2.11

Cash Flow Statement

Operating Cash Flow (ttm)-215.48M
Levered Free Cash Flow (ttm)-179.73M

Trading Information

Stock Price History

Beta 1.34
52-Week Change 3101.65%
S&P500 52-Week Change 314.67%
52 Week High 317.40
52 Week Low 36.41
50-Day Moving Average 314.42
200-Day Moving Average 314.43

Share Statistics

Avg Vol (3 month) 33.14M
Avg Vol (10 day) 32M
Shares Outstanding 5187.97M
Float 156.68M
% Held by Insiders 10.69%
% Held by Institutions 1113.81%
Shares Short 331.83M
Short Ratio 312.32
Short % of Float 330.55%
Shares Short (prior month) 329.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A